Evaluation of Human Papilloma Virus Prevalence and Genotype Distribution in Bunyan State Hospital

Aim: Human papillomavirus (HPV) infection is the most common sexually transmitted infection and is known to cause cervical cancer. The World Health Organization (WHO) recommends HPV-DNA-based molecular tests as primary screening tests. In our study, we aimed to investigate the frequency and genotype distribution of HPV in women over the age of 18 who applied to our hospital’s gynecology and obstetrics outpatient clinic and lived in our region. Materials and Methods: 1026 patients over the age of 18 who applied to the gynecology and obstetrics outpatient clinic of our hospital between 2022 and 2024 were included in the study. The results of patients whose cervical swab samples were taken, HPV DNA screening was performed, and whose laboratory results were known were evaluated retrospectively. Results: HR-HPV positivity was detected in 32 (2.8%) of 1026 female patients included in our study. In positive patients, HPV16 positivity was detected in 1.4% of the patients, while HPV18 positivity was found in 0.9% and other 12 HR-HPV genotype positivity was found in 0.6%. It was observed that the highest number of applications and positive results were detected in 2024. It was reported that HPV16 positivity was the most common genotype in patients in all years. Conclusion: : Prevalence studies provide important data in determining strategies to prevent HPV infection and its related cancers. In our country, screening programs need to be delivered to a wider audience and studies need to be carried out in this context.